PL2155169T3 - Formulacja newirapiny o przedłużonym uwalnianiu - Google Patents

Formulacja newirapiny o przedłużonym uwalnianiu

Info

Publication number: PL2155169T3
Authority: PL; Poland
Prior art keywords: nevirapine; release formulation; extended release; formulation; extended
Prior art date: 2007-06-08

Application number

PL08756672.5T

Other languages

English (en)

Inventor

Michael L. Cappola

Svetlana Sienkiewicz

Glenn Charles Snow

Feng-Jing Chen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-08

Filing date

2008-06-04

Publication date

2016-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2155169(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-04 Application filed filed Critical

2016-09-30 Publication of PL2155169T3 publication Critical patent/PL2155169T3/pl

Links

NQDJXKOVJZTUJA-UHFFFAOYSA-N nevirapine Chemical compound C12=NC=CC=C2C(=O)NC=2C(C)=CC=NC=2N1C1CC1 NQDJXKOVJZTUJA-UHFFFAOYSA-N 0.000 title 2
238000013265 extended release Methods 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960000689 nevirapine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL08756672.5T 2007-06-08 2008-06-04 Formulacja newirapiny o przedłużonym uwalnianiu PL2155169T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US94276507P	2007-06-08	2007-06-08

Publications (1)

Publication Number	Publication Date
PL2155169T3 true PL2155169T3 (pl)	2016-09-30

Family

ID=39739795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08756672.5T PL2155169T3 (pl)	2007-06-08	2008-06-04	Formulacja newirapiny o przedłużonym uwalnianiu

Country Status (28)

Country	Link
US (1)	US8460704B2 (pl)
EP (1)	EP2155169B1 (pl)
JP (1)	JP5417662B2 (pl)
KR (1)	KR101017862B1 (pl)
CN (1)	CN101784263B (pl)
AR (1)	AR066924A1 (pl)
AU (1)	AU2008262031B2 (pl)
BR (1)	BRPI0811732A2 (pl)
CA (1)	CA2687491C (pl)
CL (1)	CL2008001678A1 (pl)
CO (1)	CO6150128A2 (pl)
DK (1)	DK2155169T3 (pl)
EA (1)	EA018377B1 (pl)
EC (1)	ECSP099561A (pl)
ES (1)	ES2574836T3 (pl)
HU (1)	HUE028598T2 (pl)
IL (1)	IL199924A0 (pl)
MA (1)	MA31430B1 (pl)
MX (1)	MX2009007764A (pl)
NZ (1)	NZ578664A (pl)
PE (2)	PE20090371A1 (pl)
PL (1)	PL2155169T3 (pl)
TN (1)	TN2009000510A1 (pl)
TW (1)	TWI419716B (pl)
UA (1)	UA97971C2 (pl)
UY (1)	UY31128A1 (pl)
WO (1)	WO2008154234A2 (pl)
ZA (1)	ZA200904939B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY149159A (en)	2005-11-15	2013-07-31	Hoffmann La Roche	Method for treating joint damage
US20130172274A1 (en)	2005-12-20	2013-07-04	Duke University	Methods and compositions for delivering active agents with enhanced pharmacological properties
AU2008262031B2 (en)	2007-06-08	2011-08-25	Boehringer Ingelheim International Gmbh	Extended release formulation of nevirapine
CN105727261A (zh)	2008-06-27	2016-07-06	杜克大学	包含弹性蛋白样肽的治疗剂
US20140193491A1 (en)	2011-05-30	2014-07-10	Cipla Limited	Pharmaceutical antiretroviral composition
US20130084277A1 (en) *	2011-08-24	2013-04-04	Phasebio Pharmaceuticals, Inc.	Formulations of active agents for sustained release
CA2866133A1 (en) *	2012-03-05	2013-09-12	Cipla Limited	Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
CN104523630B (zh) *	2015-01-22	2017-08-25	山东新时代药业有限公司	一种奈韦拉平片剂
EP3153157A1 (en)	2015-10-09	2017-04-12	Teva Pharmaceutical Works Private Limited Company	Pharmaceutical composition for prolonged release of nevirapine

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5366972A (en)	1989-04-20	1994-11-22	Boehringer Ingelheim Pharmaceuticals, Inc.	5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5133974A (en)	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
CA2030056C (en)	1989-11-17	1995-10-17	Karl D. Hargrave	5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5419917A (en) *	1994-02-14	1995-05-30	Andrx Pharmaceuticals, Inc.	Controlled release hydrogel formulation
US6514530B2 (en) *	1997-09-09	2003-02-04	Alza Corporation	Dosage form comprising means for changing drug delivery shape
ES2172944T3 (es)	1997-12-05	2002-10-01	Alza Corp	Forma de dosificacion osmotica que comprende un primer y un segundo revestimiento.
DE69915346T2 (de) *	1998-12-17	2004-07-22	Alza Corp., Mountain View	Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
MX339071B (es) *	1999-03-31	2016-05-09	Janssen Pharmaceutica Nv	Almidon pregelatinizado en una formulacion de liberacion controlada.
TR200200763T2 (tr) *	1999-09-24	2003-09-22	Janssen Pharmaceutica N.V.	Antiviral bileşimler
AU2084801A (en)	1999-12-09	2001-06-18	Alza Corporation	Antiviral medication
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
WO2002092095A1 (en)	2001-05-11	2002-11-21	Boehringer Ingelheim International Gmbh	Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
US20030050620A1 (en)	2001-09-07	2003-03-13	Isa Odidi	Combinatorial type controlled release drug delivery device
AU2003287666A1 (en)	2002-11-13	2004-06-03	Control Delivery Systems, Inc.	Systemic delivery of antiviral agents
WO2004112724A2 (en)	2003-06-20	2004-12-29	Viral Genomix, Inc.	Compositions for and methods for treating hiv
CN1863512A (zh)	2003-10-01	2006-11-15	鲁宾有限公司	控释药物组合物及其制备方法
PL1696822T3 (pl)	2003-11-13	2010-08-31	Psivida Inc	Wstrzykiwane implanty o opóźnionym wydzielaniu mające matrycę rdzenia i powłokę podatne na erozję biologiczną
CA2577288C (en) *	2004-09-02	2010-11-30	Janssen Pharmaceutica N.V.	Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2006114709A1 (en) *	2005-04-25	2006-11-02	Aurobindo Pharma Limited	Pharmaceutical compositions of antiretrovirals
RS20070512A (sr)	2005-06-29	2009-01-22	Panacea Biotec Ltd.,	Farmaceutske kompozicije sa zadržanim otpuštanjem i postupci za njihovo dobijanje
EP1906937B1 (en)	2005-07-22	2016-10-19	Rubicon Research Pvt Ltd.	Novel dispersible tablet composition
FR2891459B1 (fr)	2005-09-30	2007-12-28	Flamel Technologies Sa	Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
EP1933815A2 (en) *	2005-10-14	2008-06-25	Microdose Technologies Inc.	Pharmaceutical packaging of an oral dosage combination
AU2008262031B2 (en)	2007-06-08	2011-08-25	Boehringer Ingelheim International Gmbh	Extended release formulation of nevirapine

2008
- 2008-06-04 AU AU2008262031A patent/AU2008262031B2/en not_active Ceased
- 2008-06-04 CA CA2687491A patent/CA2687491C/en active Active
- 2008-06-04 DK DK08756672.5T patent/DK2155169T3/en active
- 2008-06-04 MX MX2009007764A patent/MX2009007764A/es active IP Right Grant
- 2008-06-04 EA EA200900958A patent/EA018377B1/ru not_active IP Right Cessation
- 2008-06-04 PL PL08756672.5T patent/PL2155169T3/pl unknown
- 2008-06-04 UA UAA200908230A patent/UA97971C2/ru unknown
- 2008-06-04 EP EP08756672.5A patent/EP2155169B1/en not_active Revoked
- 2008-06-04 CN CN2008800193577A patent/CN101784263B/zh active Active
- 2008-06-04 US US12/523,226 patent/US8460704B2/en active Active
- 2008-06-04 BR BRPI0811732-2A2A patent/BRPI0811732A2/pt not_active IP Right Cessation
- 2008-06-04 NZ NZ578664A patent/NZ578664A/en not_active IP Right Cessation
- 2008-06-04 JP JP2009552940A patent/JP5417662B2/ja active Active
- 2008-06-04 WO PCT/US2008/065705 patent/WO2008154234A2/en not_active Ceased
- 2008-06-04 ES ES08756672.5T patent/ES2574836T3/es active Active
- 2008-06-04 KR KR1020097016610A patent/KR101017862B1/ko active Active
- 2008-06-04 HU HUE08756672A patent/HUE028598T2/en unknown
- 2008-06-06 CL CL2008001678A patent/CL2008001678A1/es unknown
- 2008-06-06 TW TW097121294A patent/TWI419716B/zh active
- 2008-06-06 PE PE2008000969A patent/PE20090371A1/es not_active Application Discontinuation
- 2008-06-06 PE PE2013000070A patent/PE20131035A1/es not_active Application Discontinuation
- 2008-06-06 AR ARP080102446A patent/AR066924A1/es unknown
- 2008-06-06 UY UY31128A patent/UY31128A1/es not_active Application Discontinuation
2009
- 2009-07-15 ZA ZA200904939A patent/ZA200904939B/xx unknown
- 2009-07-16 IL IL199924A patent/IL199924A0/en unknown
- 2009-07-21 CO CO09075419A patent/CO6150128A2/es unknown
- 2009-08-05 EC EC2009009561A patent/ECSP099561A/es unknown
- 2009-12-04 TN TNP2009000510A patent/TN2009000510A1/fr unknown
- 2009-12-07 MA MA32400A patent/MA31430B1/fr unknown

Also Published As

Publication number	Publication date
CN101784263A (zh)	2010-07-21
US8460704B2 (en)	2013-06-11
CO6150128A2 (es)	2010-04-20
KR101017862B1 (ko)	2011-03-04
ZA200904939B (en)	2010-04-28
EA200900958A1 (ru)	2010-04-30
UA97971C2 (ru)	2012-04-10
WO2008154234A2 (en)	2008-12-18
EP2155169A2 (en)	2010-02-24
EP2155169B1 (en)	2016-03-23
TWI419716B (zh)	2013-12-21
BRPI0811732A2 (pt)	2014-11-18
AR066924A1 (es)	2009-09-23
JP2010520891A (ja)	2010-06-17
CN101784263B (zh)	2012-11-07
PE20131035A1 (es)	2013-10-01
UY31128A1 (es)	2009-01-30
US20100278918A1 (en)	2010-11-04
JP5417662B2 (ja)	2014-02-19
HK1145806A1 (en)	2011-05-06
MX2009007764A (es)	2009-09-10
CA2687491C (en)	2011-09-20
CL2008001678A1 (es)	2009-09-11
ES2574836T3 (es)	2016-06-22
MA31430B1 (fr)	2010-06-01
ECSP099561A (es)	2009-09-29
DK2155169T3 (en)	2016-06-13
PE20090371A1 (es)	2009-04-24
CA2687491A1 (en)	2008-12-18
EA018377B1 (ru)	2013-07-30
HUE028598T2 (en)	2016-12-28
AU2008262031A1 (en)	2008-12-18
WO2008154234A3 (en)	2010-01-21
AU2008262031B2 (en)	2011-08-25
TW200916127A (en)	2009-04-16
TN2009000510A1 (en)	2011-03-31
IL199924A0 (en)	2010-04-15
KR20100020447A (ko)	2010-02-22
NZ578664A (en)	2011-11-25
WO2008154234A9 (en)	2009-11-26

Publication	Publication Date	Title
IL217153A0 (en)	2012-02-29	Controlled release formulations
PT2345410T (pt)	2021-02-08	Composição farmacêutica para libertação modificada
ZA201004793B (en)	2011-09-28	Capsule formulation
ZA201008882B (en)	2012-03-28	Controlled release of microbiocides
IL201008A0 (en)	2010-05-17	Modified release dosage forms of tacrolimus
EP2286179A4 (en)	2017-07-26	Stitching of near-nulled subaperture measurements
IL214615A0 (en)	2011-09-27	Anti-fungal formulation
ZA200904939B (en)	2010-04-28	Extended release formulation of nevirapine
GB0720716D0 (en)	2007-12-05	Novel formulation
IL210149A0 (en)	2011-03-31	Isolation of cyclopamine
GB0907003D0 (en)	2009-06-03	Formulation
GB0707463D0 (en)	2007-05-23	Formulation
GB0822633D0 (en)	2009-01-21	Formulation
EP2296709A4 (en)	2012-02-01	NIACIN FORMULATIONS WITH MODIFIED RELEASE
IL208788A (en)	2016-05-31	Pharmacy-based formulation
ZA201004772B (en)	2011-12-28	Novel formulation
IL199765A0 (en)	2010-04-15	Use of tocopherol
EP2285219A4 (en)	2013-02-20	CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM
EP2291178A4 (en)	2013-07-24	PRAMIPEXOL FORMULATIONS WITH CONTROLLED RELEASE
PH12012501255A1 (en)	2012-11-05	Sustained release formulation
TWI367205B (en)	2012-07-01	Preparation of paricalcitol
GB0814376D0 (en)	2008-09-10	Formulation
ZA201004979B (en)	2011-03-30	Extracts of sclerocarya birrea
EP2331490A4 (en)	2012-09-26	PREPARATION OF DIBUTOXYMETHANE
GB0911213D0 (en)	2009-08-12	Formulation